A double-blind , randomized , multicenter trial at @ academic and community hospitals in Europe , Australia , New Zealand , India , and North America of @ patients randomized within @ hours of presentation of an acute coronary syndrome ( ACS ) to either varespladib ( n = @ ) or placebo ( n = @ ) with enrollment between June @ , @ , and March @ , @ ( study termination on March @ , @ ) .